24 May 2013
Keywords: eu, approval, xalatan, pharmacia, upjohn, received, european
Article | 12 June 1997
Pharmacia & Upjohn has received approval from the European Unionfor its glaucoma therapy Xalatan (latanoprost). This follows its
approval and launch ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 June 1997
9 June 1997
23 May 2013
© 2013 thepharmaletter.com